ERBB2 and breast cancer: Mammographic radiomic features could also be used for the prediction of breast cancer molecular subtypes with oversimplified classifications such as triple-negative and non-triple-negative, HER2-enriched and non-HER2-enriched, and luminal and non-luminal [17].